Genenta Science (GNTA) Institutional Ownership $3.71 -0.17 (-4.38%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Genenta Science (NASDAQ:GNTA)CurrentInstitutional OwnershipPercentage15.13%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.12MNumber ofInstitutional Sellers(last 12 months)0 Get GNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Genenta Science stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GNTA Institutional Buying and Selling by Quarter Remove Ads Genenta Science Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Citadel Advisors LLC11,167$46K0.0%N/A0.061% 2/12/2025Allianz SE103,250$444K0.0%N/A0.565% 8/15/2024AlTi Global Inc.200,288$621K0.0%N/A1.099% 7/24/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 7/20/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 2/13/2023Algebris UK Ltd45,000$242K0.1%N/A0.247% (Data available from 1/1/2016 forward)Remove Ads GNTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GNTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Genenta Science shares: Bank Julius Baer & Co. Ltd Zurich ($2.46M), AlTi Global Inc. ($621K), and Allianz SE ($444K), Citadel Advisors LLC ($46K).Learn more on GNTA's institutional investors. What percentage of Genenta Science stock is owned by institutional investors? 15.13% of Genenta Science stock is owned by institutional investors. Learn more on GNTA's institutional investor holdings. Which institutional investors have been buying Genenta Science stock? The following institutional investors have purchased Genenta Science stock in the last 24 months: Bank Julius Baer & Co. Ltd Zurich ($825.09K), AlTi Global Inc. ($200.29K), Allianz SE ($103.25K), and Citadel Advisors LLC ($11.17K). How much institutional buying is happening at Genenta Science? Institutional investors have bought a total of 1,139,799 shares in the last 24 months. This purchase volume represents approximately $5.98M in transactions. Related Companies Taysha Gene Therapies Institutional Ownership Esperion Therapeutics Institutional Ownership Alpha Teknova Institutional Ownership Atai Life Sciences Institutional Ownership Atyr PHARMA Institutional Ownership Candel Therapeutics Institutional Ownership ProKidney Institutional Ownership COMPASS Pathways Institutional Ownership Compass Therapeutics Institutional Ownership Prime Medicine Institutional Ownership This page (NASDAQ:GNTA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
